As deadline looms, FDA advisers debate coronavirus boosters for fall

by

Food and Drug Administration advisers met Wednesday to discuss when, whether and how to modify coronavirus shots to keep up with the evolving threat.

View original article
Contributor: Carolyn Y. Johnson